Healthcare
Rabo Capital looks to sell DORC
The private equity division of Rabobank, Rabo Capital, is planning to sell portfolio company Dutch Ophthalmic Research Centre (DORC).
Principia backs Im3D with €2m
Italian VC investor Principia has injected €2m into oncologic medical imaging company Im3D Clinic Sud.
VC-backed Prosensa raises $78m in IPO
Dutch biotechnology company Prosensa Holding, which is backed by a consortium of venture capital firms, has listed on the Nasdaq Global Select Market in an IPO valuing the business at $408m.
Heptares raises $21m from Clarus and Takeda
Venture capital firms Clarus Ventures and Takeda Ventures have backed a $21m round for UK-based drug discovery and development company Heptares Therapeutics, alongside the Stanley Family Foundation.
Karolinska backs Forendo Pharma
Karolinska Development has invested €1.2m in a series-A funding round for Finnish drug development company Forendo Pharma.
Investinor leads NOK 37.5m round in BerGenBio
Investinor has led a NOK 37.5m funding round in Norwegian biotechnology company BerGenBio.
Arkéa invests €2m in Lyamtech
Arkéa Capital Investissement has invested €2m in orthopaedic footwear company Lyamtech.
Sarsia Seed et al. pump NOK 5.5m into Vaccibody
Norwegian pharmaceutical firm Vaccibody has received NOK 5.5m in funding from existing investors including Sarsia Seed.
Gimv and EdRip back Complix with €12m
Gimv and Edmond de Rothschild Investment Partners (EdRip) have led a €12m series-B round for Belgian biopharmaceutical company Complix.
Catapult et al. invest in Monica Healthcare
Catapult Venture Managers, East Midlands Business Angels, New Hill Management and private investors have made a further cash injection into Monica Healthcare.
Eurazeo buys Péters Surgical from UI Gestion
Eurazeo PME has acquired French medical devices manufacturer Péters Surgical from UI Gestion in a transaction that values the firm at €45m.
Blue Sea Capital’s MediGroup acquires Jedro
Blue Sea Capital's portfolio company MediGroup has agreed to acquire Serbian outpatient services provider Dom Zdravlja Jedro from Delta Generali Insurance.
VC-backed Cardio3 announces launch of €28.4m IPO
Cardio3 Biosciences, a Belgian pharmaceutical company backed by a number of venture capital investors, has launched the subscription period of its IPO.
NVM backs Kirton MBO
NVM Private Equity has backed the £5.5m MBO of Kirton Group, a UK manufacturer and supplier of specialist seating products for the elderly and disabled.
Index injects $11m into XO1 Ltd
Index Ventures has made an $11m capital commitment to XO1 Ltd, a new biotechnology company based in Hertfordshire.
Clave Mayor to divest Gadea
Spanish venture capital investor Clave Mayor is to divest its 10% stake in pharmaceuticals developer Gadea.
Neomed and Defi back CHF 1.3m round for Diagnoplex
Neomed and Defi Gestion have taken part in a CHF 1.3m funding round for Diagnoplex SA, a Swiss developer of diagnostics for colon cancer.
Algot Invest et al. back Targovax
Algot Invest and other investors have injected $1.3m into Targovax, a Norwegian cancer vaccine specialist.
Cerus Endovascular raises £1.5m from Spark Impact
Medical devices company Cerus Endovascular has completed a £1.5m funding round led by the North West Fund for Biomedical.
VC-backed Cardio3 announces IPO plans
Belgian biopharmaceutical company Cardio3 Biosciences, which is backed by a consortium of venture capital firms, has announced that it is considering listing new shares in an IPO.
DFJ Esprit et al. back extended £6.9m Horizon Discovery series-C
A consortium of venture capital firms and private investors has injected a further £6.9m into Horizon Discovery as part of the final close of the company's extended series-C round.
TCR exits Laboratoires Chemineau in trade sale
TCR Capital has sold French pharmaceutical company Laboratoires Chemineau to Groupe Anjac, generating a multiple in excess of 3x and an IRR of more than 20%.
Fountain Healthcare backs €9.2m Trino Therapeutics round
Fountain Healthcare Partners has invested in a €9.2m series-A funding round for Ireland-based Trino Therapeutics Ltd, alongside British grant-giving body Wellcome Trust.
AAA raises €4.8m from Seventure et al.
French pharmaceutical firm Advanced Accelerator Applications (AAA) has raised €4.8m from existing and new investors, including incoming venture capital investor Seventure Partners.